These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

307 related articles for article (PubMed ID: 30935894)

  • 21. Grape Seed Extract Eliminates Visceral Allodynia and Colonic Hyperpermeability Induced by Repeated Water Avoidance Stress in Rats.
    Arie H; Nozu T; Miyagishi S; Ida M; Izumo T; Shibata H
    Nutrients; 2019 Nov; 11(11):. PubMed ID: 31689935
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Chitin-glucan improves important pathophysiological features of irritable bowel syndrome.
    Valibouze C; Dubuquoy C; Chavatte P; Genin M; Maquet V; Modica S; Desreumaux P; Rousseaux C
    World J Gastroenterol; 2024 Apr; 30(16):2258-2271. PubMed ID: 38690023
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Visceral hypersensitivity in irritable bowel syndrome.
    Kanazawa M; Hongo M; Fukudo S
    J Gastroenterol Hepatol; 2011 Apr; 26 Suppl 3():119-21. PubMed ID: 21443723
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Imeglimin prevents visceral hypersensitivity and colonic hyperpermeability in irritable bowel syndrome rat model.
    Nozu T; Miyagishi S; Ishioh M; Takakusaki K; Okumura T
    J Pharmacol Sci; 2023 Sep; 153(1):26-30. PubMed ID: 37524451
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Schisandra chinensis reverses visceral hypersensitivity in a neonatal-maternal separated rat model.
    Yang JM; Xian YF; Ip PS; Wu JC; Lao L; Fong HH; Sung JJ; Berman B; Yeung JH; Che CT
    Phytomedicine; 2012 Mar; 19(5):402-8. PubMed ID: 22230486
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Role of corticotropin-releasing hormone in irritable bowel syndrome and intestinal inflammation.
    Fukudo S
    J Gastroenterol; 2007 Jan; 42 Suppl 17():48-51. PubMed ID: 17238026
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Repeated water avoidance stress induces visceral hypersensitivity: Role of interleukin-1, interleukin-6, and peripheral corticotropin-releasing factor.
    Nozu T; Miyagishi S; Nozu R; Takakusaki K; Okumura T
    J Gastroenterol Hepatol; 2017 Dec; 32(12):1958-1965. PubMed ID: 28299830
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Translational evaluation of Gelsectan
    Inczefi O; Eutamene H; Placide F; Tondereau V; Pallagi P; Bagyánszki M; Bódi N; Gémes N; Szebeni G; Molnár T; Theodorou V; Róka R
    United European Gastroenterol J; 2024 Oct; 12(8):1102-1113. PubMed ID: 39106086
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Chronic psychosocial stress induces reversible mitochondrial damage and corticotropin-releasing factor receptor type-1 upregulation in the rat intestine and IBS-like gut dysfunction.
    Vicario M; Alonso C; Guilarte M; Serra J; Martínez C; González-Castro AM; Lobo B; Antolín M; Andreu AL; García-Arumí E; Casellas M; Saperas E; Malagelada JR; Azpiroz F; Santos J
    Psychoneuroendocrinology; 2012 Jan; 37(1):65-77. PubMed ID: 21641728
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A Monoclonal Anti-Calcitonin Gene-Related Peptide Antibody Decreases Stress-Induced Colonic Hypersensitivity.
    Noor-Mohammadi E; Ligon CO; Mackenzie K; Stratton J; Shnider S; Greenwood-Van Meerveld B
    J Pharmacol Exp Ther; 2021 Nov; 379(3):270-279. PubMed ID: 34620725
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Selective corticotropin-releasing factor 1 receptor antagonist E2508 reduces restraint stress-induced defecation and visceral pain in rat models.
    Taguchi R; Shikata K; Furuya Y; Hirakawa T; Ino M; Shin K; Shibata H
    Psychoneuroendocrinology; 2017 Jan; 75():110-115. PubMed ID: 27810704
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Berberine alleviates visceral hypersensitivity in rats by altering gut microbiome and suppressing spinal microglial activation.
    Zhang JD; Liu J; Zhu SW; Fang Y; Wang B; Jia Q; Hao HF; Kao JY; He QH; Song LJ; Liu F; Zhu BL; Owyang C; Duan LP
    Acta Pharmacol Sin; 2021 Nov; 42(11):1821-1833. PubMed ID: 33558654
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Modulation of enteric neurons by interleukin-6 and corticotropin-releasing factor contributes to visceral hypersensitivity and altered colonic motility in a rat model of irritable bowel syndrome.
    Buckley MM; O'Halloran KD; Rae MG; Dinan TG; O'Malley D
    J Physiol; 2014 Dec; 592(23):5235-50. PubMed ID: 25260633
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Protease Activated Receptor-2 Induces Immune Activation and Visceral Hypersensitivity in Post-infectious Irritable Bowel Syndrome Mice.
    Du L; Long Y; Kim JJ; Chen B; Zhu Y; Dai N
    Dig Dis Sci; 2019 Mar; 64(3):729-739. PubMed ID: 30446929
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Role of corticotropin releasing factor receptor subtype 1 in stress-related functional colonic alterations: implications in irritable bowel syndrome.
    Taché Y; Martinez V; Million M; Maillot C
    Eur J Surg Suppl; 2002; (587):16-22. PubMed ID: 16144197
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Inhibitory effects of patchouli alcohol on stress-induced diarrhea-predominant irritable bowel syndrome.
    Zhou TR; Huang JJ; Huang ZT; Cao HY; Tan B
    World J Gastroenterol; 2018 Feb; 24(6):693-705. PubMed ID: 29456408
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effect of water extracts from Cynanchum thesioides (Freyn) K. Schum. on visceral hypersensitivity and gut microbiota profile in maternally separated rats.
    Lingpeng P; Jingzhu S; Wei L; Enqi W; Yaqin L
    J Ethnopharmacol; 2021 Jan; 264():113352. PubMed ID: 32891821
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pharmacological evaluation of a novel corticotropin-releasing factor 1 receptor antagonist T-3047928 in stress-induced animal models in a comparison with alosetron.
    Itomi Y; Tanaka T; Matsushita K; Kawamura T; Kojima T; Aso K; Matsumoto-Okano S; Tsukimi Y
    Neurogastroenterol Motil; 2020 May; 32(5):e13795. PubMed ID: 31970891
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Methyl-orvinol-Dual activity opioid receptor ligand inhibits gastrointestinal transit and alleviates abdominal pain in the mouse models mimicking diarrhea-predominant irritable bowel syndrome.
    Zielińska M; Jarmuż A; Wasilewski A; Cami-Kobeci G; Husbands S; Fichna J
    Pharmacol Rep; 2017 Apr; 69(2):350-357. PubMed ID: 28187396
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Adrenal hormone response and psychophysiological correlates under psychosocial stress in individuals with irritable bowel syndrome.
    Sugaya N; Izawa S; Kimura K; Ogawa N; Yamada KC; Shirotsuki K; Mikami I; Hirata K; Nagano Y; Nomura S; Shimada H
    Int J Psychophysiol; 2012 Apr; 84(1):39-44. PubMed ID: 22251450
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.